BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang D, Xiao M, Wan ZM, Lin X, Li QY, Zheng SS. Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges. World J Gastrointest Surg 2023; 15(4): 544-552 [PMID: 37206072 DOI: 10.4240/wjgs.v15.i4.544]
URL: https://www.wjgnet.com/1948-9366/full/v15/i4/544.htm
Number Citing Articles
Mansour Bahardoust, Maryam Zolfaghari Dehkharghani, Pouya Ebrahimi, Maryam Najafirashed, Safa Mousavi, Meisam Haghmoradi, Mohsen Khaleghian, Adnan Tizmaghz. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort studyBMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02236-8
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicineWorld Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
Jianping Wang, Peipei Cong, Zhipeng Jin, Lingli Liu, Dongxu Sun, Wenjing Zhu, Guangjun Shi. A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genesScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38197-4